Literature DB >> 16265712

Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.

John R Kirwan1, Sarah E Hewlett, Turid Heiberg, Rod A Hughes, Maggie Carr, Maggie Hehir, Tore K Kvien, Patricia Minnock, Stanton P Newman, Enid M Quest, Erik Taal, Janney Wale.   

Abstract

The Patient Perspective Workshop at OMERACT 7 addressed the question of assessing the outcomes of intervention in rheumatoid arthritis (RA) from the perspective of those who experience the disease. A particular emphasis at this workshop was placed on fatigue, but other areas included well-being, real-time assessment, patient priorities, and needs in early and late disease. Through a series of overview presentations, discussion groups, and plenary sessions, workshop participants (who included 19 patients) clarified what is known and what are the outstanding issues for future research. The importance of further work on clarifying the validity of fatigue measurements in RA has been confirmed, and with at least one suitable instrument available there will be strong pressure to include fatigue in a redefined core set of outcome measures in RA. In the other 4 areas covered there are important issues that can be addressed by enquiry and experiment and that together provide a challenging research agenda. At the final plenary session the OMERACT conference endorsed, by a large majority, the proposal that fatigue may warrant consideration for inclusion in the OMERACT core set for RA.

Entities:  

Mesh:

Year:  2005        PMID: 16265712

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  83 in total

1.  Patterns of background factors related to early RA patients' conceptions of the cause of their disease.

Authors:  Ulrika Bergsten; Stefan Bergman; Bengt Fridlund; Lars Alfredsson; Anita Berglund; Barbro Arvidsson; Ingemar F Petersson
Journal:  Clin Rheumatol       Date:  2010-08-24       Impact factor: 2.980

2.  Core outcome domains for clinical trials in non-specific low back pain.

Authors:  Alessandro Chiarotto; Richard A Deyo; Caroline B Terwee; Maarten Boers; Rachelle Buchbinder; Terry P Corbin; Leonardo O P Costa; Nadine E Foster; Margreth Grotle; Bart W Koes; Francisco M Kovacs; Chung-Wei Christine Lin; Chris G Maher; Adam M Pearson; Wilco C Peul; Mark L Schoene; Dennis C Turk; Maurits W van Tulder; Raymond W Ostelo
Journal:  Eur Spine J       Date:  2015-04-05       Impact factor: 3.134

Review 3.  Incorporating the patient's perspective in outcomes research.

Authors:  Betty Hsiao; Liana Fraenkel
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

Review 4.  The COMET Handbook: version 1.0.

Authors:  Paula R Williamson; Douglas G Altman; Heather Bagley; Karen L Barnes; Jane M Blazeby; Sara T Brookes; Mike Clarke; Elizabeth Gargon; Sarah Gorst; Nicola Harman; Jamie J Kirkham; Angus McNair; Cecilia A C Prinsen; Jochen Schmitt; Caroline B Terwee; Bridget Young
Journal:  Trials       Date:  2017-06-20       Impact factor: 2.279

5.  Patient and public involvement in patient-reported outcome measures: evolution not revolution.

Authors:  Sophie Staniszewska; Kirstie L Haywood; Jo Brett; Liz Tutton
Journal:  Patient       Date:  2012       Impact factor: 3.883

6.  Randomized clinical trials as reflexive-interpretative process in patients with rheumatoid arthritis: a qualitative study.

Authors:  Mercedes de Jorge; Sonia Parra; Jenny de la Torre-Aboki; Gabriel Herrero-Beaumont
Journal:  Rheumatol Int       Date:  2015-01-31       Impact factor: 2.631

7.  OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Authors:  Joanna C Robson; Gunnar Tomasson; Nataliya Milman; Sue Ashdown; Annelies Boonen; George C Casey; Peter F Cronholm; David Cuthbertson; Jill Dawson; Haner Direskeneli; Ebony Easley; Tanaz A Kermani; John T Farrar; Don Gebhart; Georgia Lanier; Raashid A Luqmani; Alfred Mahr; Carol A McAlear; Jacqueline Peck; Beverley Shea; Judy A Shea; Antoine G Sreih; Peter S Tugwell; Peter A Merkel
Journal:  J Rheumatol       Date:  2017-09-01       Impact factor: 4.666

8.  Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment.

Authors:  Peter M ten Klooster; Martine M Veehof; Erik Taal; Piet L C M van Riel; Mart A F J van de Laar
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

9.  Exploring Tai Chi in rheumatoid arthritis: a quantitative and qualitative study.

Authors:  Till Uhlig; Camilla Fongen; Eldri Steen; Anne Christie; Sigrid Ødegård
Journal:  BMC Musculoskelet Disord       Date:  2010-03-05       Impact factor: 2.362

10.  Fatigue, pain and patient global assessment responses to biological treatment are unpredictable, and poorly inter-connected in individual rheumatoid arthritis patients followed in the daily clinic.

Authors:  Ole Rintek Madsen; Eva Marie Egsmose
Journal:  Rheumatol Int       Date:  2016-07-23       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.